Relaxation Techniques + Massage for Delirium in Critically Ill Patients
(REPOSE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Methodology: Pilot randomized controlled trial with 1 intervention and 1 parallel standard care group to assess the feasibility and treatment effect of a multimodal integrative intervention for delirium prevention and associated detrimental effects.Duration: 2 years, two months. Study Center(s): Multi-center (2 sites) Aim: To assess feasibility and measures of effect of a multimodal intervention consisting of relaxation with guided imagery (RGI), and moderate pressure massage on physiological and psychological outcomes of critically ill patients.Objectives: a) assess clinical trial feasibility with pre-defined goals (enrollment, randomization, adherence, timing of intervention, workload), b) calculate estimates and variance of treatment effect across outcome measures, c) calculate confidence intervals (CI) of incidence proportions, means and standard deviation (SD) of outcome measures in study groups., d) explore underlying physiological mechanisms of efficacy Number of Subjects: 60 participants per arm. Total: 120 participants Diagnosis and Main Inclusion Criteria: Critical illness Inclusion criteria: a) Age over 18 years, b) ICDSC:0-3. Exclusion Criteria: Patients: a) with expected ICU LOS\< 72 hours, b) with acute neurological illness/ trauma, persistent sedation or coma, c) with current history of severe mental health problems and dementia, as per history and psychiatrist assessment, c) with hearing impairment or conditions not permitting use of headphones, e) on neuro-muscular blockers, f) with substance/ alcohol withdrawal, g) enrolled in trials of sedatives, antipsychotics.Intervention: REPOSE intervention (a multimodal relaxation intervention) It includes: a) relaxation and guided imagery (RGI) (40 min, headphones), b) a brief moderate pressure massage session (massage: 15 min). RGI involves: a) guided relaxation, b) a structured guided imagery script and c) music for 15 min (Mozart piano sonata KV283, G major (2 3) II Andante). Duration of administration: Up to 5 days while participants still in the ICU.Reference therapy: Standard care plus placebo to maintain blinding. Statistical Methodology: Outcomes will be analyzed longitudinally over 5 days by logistic regression model based on generalized estimating equations (GEE) with AR(1) correlation structure. Confidence intervals will be presented with estimated effects. Primary analysis will be based on all available data utilizing data from all assessments.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you cannot participate if you are on neuro-muscular blockers or enrolled in trials involving sedatives or antipsychotics.
Is the combination of relaxation techniques and massage safe for humans?
How does the REPOSE intervention treatment differ from other treatments for delirium in critically ill patients?
The REPOSE intervention is unique because it combines relaxation techniques, guided imagery (using mental visualization to promote relaxation), and moderate pressure massage to prevent delirium in critically ill patients, whereas most existing treatments focus on medication or environmental changes. This multimodal approach targets both the mind and body, aiming to reduce stress and improve patient outcomes without relying on drugs.12567
What data supports the effectiveness of the treatment RGI & Massage, REPOSE intervention, Relaxation and Guided Imagery (RGI), Moderate Pressure Massage for delirium in critically ill patients?
Research suggests that relaxation and guided imagery can improve sleep in critically ill adults, which may indirectly help with delirium. Additionally, massage has been studied for its potential to affect delirium and sleep, indicating that these components might be beneficial in managing delirium in critically ill patients.12358
Who Is on the Research Team?
Elisavet Papathanasoglou, PhD
Principal Investigator
University of Alberta
Are You a Good Fit for This Trial?
This trial is for adults over 18 in the ICU with mild to no delirium. They can't be expected to leave the ICU within 72 hours, have acute brain issues or deep sedation, severe mental health problems including dementia, hearing issues preventing headphone use, muscle blocker drugs, substance withdrawal symptoms, or be in other trials for sedatives.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the REPOSE intervention, which includes relaxation and guided imagery with background music and a brief moderate pressure massage session, administered once daily for up to 5 consecutive days while in the ICU.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including follow-up 48-96 hours after ICU discharge and 3 months post-hospital discharge.
Long-term Follow-up
Participants' quality of life and other outcomes are assessed at 6 months post-hospital discharge.
What Are the Treatments Tested in This Trial?
Interventions
- RGI & Massage
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Royal Alexandra Hospital
Collaborator